FDA Issues Draft Guidance on Labeling of Combination Products

The GMP Letter
A A
The FDA released draft guidance on the content and formatting of Instructions for Use (IFU) for drug- or biologic-device combinations.

To View This Article:

Login

Subscribe To The GMP Letter

Buy This Article Now

Add this article to your cart for $40.00